New Type of Sound Wave May Allow for Inhalable Vaccines

A new form of hybridized sound waves developed by Australian researchers may allow drugs and vaccines to be delivered to the body through a nebulizer in a fine mist inhaled into the lungs.

Studies Suggest Flu Vaccine Is Long-Lasting and Reduces Hospitalizations

Two studies presented at the International Conference on Emerging Infectious Diseases show that the influenza vaccine can protect for six months, last throughout the flu season and reduce hospitalization in children.

FDA Grants 12-Year Exclusivity to Flublok

The U.S. Food and Drug Administration(FDA) has granted exclusivity to Flublok influenza vaccine for a period of 12 years.

Shingles Vaccine Reduces Risk of Long-Term Pain in Patients

A new study shows that people who receive a shingles vaccine but still contract shingles have a lower risk of developing post-herpatic neuralgia (PHN).

Personal Melanoma Vaccines Evoke Immune Response

In a first-in-people clinical trial, personalized tailor-made melanoma vaccines given to three patients with advanced melanoma appeared to increase the number and diversity of cancer-fighting T cells responding to the tumors.

More Is Better: High-Dose Flu Vaccine Helps Protect Seniors

Influenza vaccination represents one of the most cost-effective treatment modalities available to the older adult population.

AMA Adopts More Stringent Vaccine Requirement Policy

At its annual meeting in June, the American Medical Association (AMA) adopted a new policy to seek more stringent state immunization requirements to allow exemptions only for medical reasons.

Studies Find Interventions Increase HPV Vaccine Coverage

Three recent studies have found that interventions increase the rates of human papillomavirus (HPV) vaccination among teens and young women.

Flu Vaccine May Protect Against Guillain-Barré Syndrome

A new simulation study that evaluated the relationship between Guillain-Barré syndrome (GBS) risk and influenza vaccine and illness suggests that the vaccine reduces the risk for GBS.

Pertussis Vaccine Prevents Infant Mortality

Researchers investigated the role of one or more pertussis vaccinations in preventing pertussis-related deaths and risk markers for death among infants aged younger than 42 days.